© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 3, 206-214,
February 5, 2003
© 2003 Oxford University Press
ARTICLE |
Treatment of Former Smokers With 9-cis-Retinoic Acid Reverses Loss of Retinoic Acid Receptor-
Expression in the Bronchial Epithelium: Results From a Randomized Placebo-Controlled Trial
Affiliations of authors: J. M. Kurie, R. Lotan, J. S. Lee, F. R. Khuri, W. K. Hong (Department of Thoracic/Head and Neck Medical Oncology), J. J. Lee, D. D. Liu (Department of Biostatistics), R. C. Morice (Department of Pulmonary Medicine), X.-C. Xu (Department of Cancer Prevention), J. Y. Ro (Department of Pathology), W. N. Hittelman (Department of Experimental Therapeutics), G. L. Walsh, J. A. Roth (Department of Thoracic and Cardiovascular Surgery), The University of Texas M. D. Anderson Cancer Center, Houston; J. D. Minna, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas.
Correspondence to: Waun Ki Hong, M.D., Box 432, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 (e-mail: whong{at}mdanderson.org).
Background: Loss of retinoic acid receptor beta (RAR-
) expression in the bronchial epithelium is considered a biomarker of preneoplasia. Retinoids can restore expression of this receptor and, presumably, halt the progression of carcinogenesis. This study was designed to investigate whether either of two retinoid-based regimens, 9-cis-retinoic acid (RA) or 13-cis-RA plus 
-tocopherol (AT), could reverse RAR- expression loss in former smokers after 3 months of treatment. Methods: Individuals (n = 226) who had smoked at least 20 pack-years and had ceased smoking for at least 12 months were randomly assigned to receive 3 months of daily oral 9-cis-RA (100 mg), 13-cis-RA (1 mg/kg) + AT (1200 IU), or placebo. Bronchoscopy and biopsy at six predetermined sites of the bronchial tree were performed before treatment and at 3 and 6 months thereafter. Specimens were evaluated for squamous metaplasia, dysplasia, and RAR- expression. McNemar’s test was used to test changes in RAR- expression and squamous metaplasia within each treatment group, and a generalized estimating equations model was applied to model the treatment effect, adjusting for covariates. All statistical tests were two-sided. Results: A total of 177 assessable subjects completed at least 3 months of therapy and underwent at least the baseline and 3-month bronchoscopic evaluations with biopsies. RAR- was detected in 69.7% of all baseline biopsy samples, and metaplasia was evident in 6.9% of all baseline samples from 240 subjects. Restoration of RAR- expression (P = .03) and reduction of metaplasia (P = .01) were found in the 9-cis-RA group. After adjustment for years of smoking, packs/day smoked, and metaplasia, treatment with 9-cis-RA, but not with 13-cis-RA + AT, led to a statistically significant increase in RAR- expression compared with placebo (P = .03). Conclusion: 9-cis-RA treatment can restore RAR- expression in the bronchial epithelium of former smokers, raising the possibility that this retinoid has potential chemopreventive properties in former smokers.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. S. Kim, W. K. Hong, J. J. Lee, L. Mao, R. C. Morice, D. D. Liu, C. A. Jimenez, G. A. Eapen, R. Lotan, X. Tang, et al. Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers Cancer Prevention Research, February 1, 2010; 3(2): 148 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kelly, J. Kittelson, W. A. Franklin, T. C. Kennedy, C. E. Klein, R. L. Keith, E. C. Dempsey, M. Lewis, M. K. Jackson, F. R. Hirsch, et al. A Randomized Phase II Chemoprevention Trial of 13-CIS Retinoic Acid with Or without {alpha} Tocopherol or Observation in Subjects at High Risk for Lung Cancer Cancer Prevention Research, May 1, 2009; 2(5): 440 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Song, B. Guan, T. Men, A. Hoque, R. Lotan, and X.-C. Xu Antitumor Effect of Retinoic Acid Receptor-{beta}2 Associated with Suppression of Cyclooxygenase-2 Cancer Prevention Research, March 1, 2009; 2(3): 274 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. Hittelman, D. D. Liu, J. M. Kurie, R. Lotan, J. S. Lee, F. Khuri, H. Ibarguen, R. C. Morice, G. Walsh, J. A. Roth, et al. Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids J Natl Cancer Inst, November 7, 2007; 99(21): 1603 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Szabo Proliferative Changes in Chemoprevention Trials: Learning From Secondary Endpoints J Natl Cancer Inst, November 7, 2007; 99(21): 1565 - 1567. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. van den Berg, H. van Tinteren, N. van Zandwijk, C. Visser, A. Pasic, C. Kooi, T. G. Sutedja, P. Baas, K. Grunberg, W. J. Mooi, et al. The Influence of Fluticasone Inhalation on Markers of Carcinogenesis in Bronchial Epithelium Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 1061 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tefferi Pathogenesis of Myelofibrosis With Myeloid Metaplasia J. Clin. Oncol., November 20, 2005; 23(33): 8520 - 8530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Sabichi, X. Xu, and S. M. Lippman RAR{beta}1': Primed To Fight Retinoid Resistance in Lung Carcinogenesis J Natl Cancer Inst, November 16, 2005; 97(22): 1632 - 1633. [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Lee, Y. S. Chang, J.-Y. Han, D. D. Liu, J. J. Lee, R. Lotan, M. R. Spitz, and W. K. Hong Effects of 9-cis-Retinoic Acid on the Insulin-Like Growth Factor Axis in Former Smokers J. Clin. Oncol., July 1, 2005; 23(19): 4439 - 4449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Hirsch and S. M. Lippman Advances in the Biology of Lung Cancer Chemoprevention J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Han, D. D. Liu, J. J. Lee, J. Kurie, R. Lotan, W. K. Hong, and H.-Y. Lee 9-cis-Retinoic Acid Treatment Increases Serum Concentrations of {alpha}-Tocopherol in Former Smokers Clin. Cancer Res., March 15, 2005; 11(6): 2305 - 2311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brabender, R. Metzger, D. Salonga, K. D. Danenberg, P. V. Danenberg, A. H. Holscher, and P. M. Schneider Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis Carcinogenesis, March 1, 2005; 26(3): 525 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Mooney, A. M. Madsen, D. Tang, M. A. Orjuela, W.-Y. Tsai, E. R. Garduno, and F. P. Perera Antioxidant Vitamin Supplementation Reduces Benzo(a)pyrene-DNA Adducts and Potential Cancer Risk in Female Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 237 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ruzicka, F. G. Larsen, D. Galewicz, A. Horvath, P. J. Coenraads, K. Thestrup-Pedersen, J. P. Ortonne, C. C. Zouboulis, M. Harsch, T. C. Brown, et al. Oral Alitretinoin (9-cis-Retinoic Acid) Therapy for Chronic Hand Dermatitis in Patients Refractory to Standard Therapy: Results of a Randomized, Double-blind, Placebo-Controlled, Multicenter Trial Arch Dermatol, December 1, 2004; 140(12): 1453 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri and R. Lotan Retinoids in Lung Cancer: Friend, Foe, or Fellow Traveler? J. Clin. Oncol., September 1, 2004; 22(17): 3435 - 3437. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer J. Clin. Oncol., September 1, 2004; 22(17): 3443 - 3450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Means-Markwell, R. I. Linnoila, J. Williams, P. A. Janne, F. Kaye, K. O'Neil, and B. E. Johnson Prospective Study of the Airways and Pulmonary Parenchyma of Patients at Risk for a Second Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5915 - 5921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman Frontiers in Cancer Prevention Research Cancer Res., September 15, 2003; 63(18): 5649 - 5655. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Vourlekis and E. Szabo Predicting Success in Cancer Prevention Trials J Natl Cancer Inst, February 5, 2003; 95(3): 178 - 179. [Full Text] [PDF]
|
|